...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.
【24h】

Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.

机译:长期用氯氮平治疗牛肾上腺髓质细胞中去甲肾上腺素转运蛋白功能改变的两个阶段。

获取原文
获取原文并翻译 | 示例

摘要

The effects of long-term treatment with clozapine, a prototype of atypical antipsychotic drugs, on the functional activity, synthesis and mRNA of norepinephrine (NE) transporter were examined in bovine adrenal medullary cells in culture. Treatment of cells with clozapine at 0.1-3.0 microM concentrations produced dual phases of changes in [(3)H]NE uptake, i.e. the first phase showed a decrease in [(3)H]NE uptake at 2-48 h, and the following phase showed an increase in uptake at 72-168 h. Treatment with clozapine for 6 h decreased V(max) to 40% of the control without changing the K(m) value for [(3)H]NE uptake. However, treatment with clozapine for 96 h increased V(max) by 56% over the control without a change in K(m). Scatchard plot analysis of [(3)H]desipramine (DMI) binding to membranes isolated from cells treated with clozapine for 6 h revealed a decrease in B(max) without any change in K(d); in contrast, treatment with clozapine for 96 h caused an increase in B(max) without any change in K(d). Both actinomycin D and cycloheximide, which are inhibitors of protein synthesis, suppressed the clozapine (96 h)-induced increase in [(3)H]NE uptake. Treatment of cells with clozapine for 12-96 h increased the level of NE transporter mRNA in a concentration-dependent manner (0.3-3.0 microM). These findings suggest that treatment of cells with clozapine results in the down-regulation and subsequent up-regulation of NE transporter. The latter change may be caused by the synthesis of new proteins of NE transporter via an increase in its mRNA.
机译:在培养的牛肾上腺髓质细胞中检查了长期使用非典型抗精神病药原型氯氮平对去甲肾上腺素(NE)转运蛋白的功能活性,合成和mRNA的影响。用0.1-3.0 microM浓度的氯氮平处理细胞会产生[(3)H] NE摄取变化的两个阶段,即第一阶段在2-48 h时显示[(3)H] NE摄取减少,并且随后的阶段显示在72-168小时的摄取增加。氯氮平治疗6 h不会将V(max)降至对照组的40%,而不会改变[(3)H] NE吸收的K(m)值。但是,用氯氮平治疗96 h可使V(max)比对照组增加56%,而K(m)不变。 Scatchard图分析[(3)H] desipramine(DMI)与从氯氮平处理6 h的细胞分离的膜结合,发现B(max)降低,而K(d)不变。相反,氯氮平治疗96 h导致B(max)增加,而K(d)没有任何变化。放线菌素D和环己酰亚胺都是蛋白质合成的抑制剂,它们抑制了氯氮平(96 h)诱导的[(3)H] NE吸收增加。用氯氮平处理细胞12-96小时以浓度依赖的方式(0.3-3.0 microM)增加NE转运蛋白的水平。这些发现表明,用氯氮平处理细胞会导致NE转运蛋白的下调和随后的上调。后者的变化可能是由于NE转运蛋白的mRNA含量增加而合成的新蛋白引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号